IGC Pharma, Inc. (IGC)

IGC Pharma Revenue

IGC Pharma had revenue of $328.00K in the quarter ending June 30, 2025, with 20.59% growth. This brings the company's revenue in the last twelve months to $1.33M, up 24.95% year-over-year. In the fiscal year ending March 31, 2025, IGC Pharma had annual revenue of $1.27M, down -5.50%.

• Revenue (ttm): $1.33M
• Revenue Growth: +24.95%
• P/S Ratio: 25.84
• Revenue / Employee: $18,957
• Employees: 70
• Market Cap: 39.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.27M	-74.00K	-5.50%
Mar 31, 2024	1.35M	434.00K	47.64%
Mar 31, 2023	911.00K	514.00K	129.47%
Mar 31, 2022	397.00K	-501.00K	-55.79%
Mar 31, 2021	898.00K	-3.17M	-77.95%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.